BlackRock’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Sell
374,516
-91,298
-20% -$74.7K ﹤0.01% 4721
2026
Q1
$289K Buy
465,814
+3,461
+0.7% +$3K ﹤0.01% 4664
2025
Q4
$546K Buy
462,353
+1,747
+0.4% +$2.21K ﹤0.01% 4461
2025
Q3
$686K Buy
460,606
+2,100
+0.5% +$3.7K ﹤0.01% 4391
2025
Q2
$890K Buy
458,506
+32,640
+8% +$42.7K ﹤0.01% 4290
2025
Q1
$520K Sell
425,866
-1,662
-0.4% -$4.09K ﹤0.01% 4386
2024
Q4
$1.29M Sell
427,528
-63
-0% -$177 ﹤0.01% 4161
2024
Q3
$1.08M Sell
427,591
-139,615
-25% -$497K ﹤0.01% 4157
2024
Q2
$2.67M Sell
567,206
-476,022
-46% -$2.51M ﹤0.01% 3882
2024
Q1
$5.92M Sell
1,043,228
-34,828
-3% -$230K ﹤0.01% 3607
2023
Q4
$7.14M Buy
1,078,056
+58,018
+6% +$335K ﹤0.01% 3544
2023
Q3
$8.16M Buy
1,020,038
+8,515
+0.8% +$79.1K ﹤0.01% 3451
2023
Q2
$10.2M Buy
1,011,523
+992,960
+5,349% +$10.2M ﹤0.01% 3407
2023
Q1
$198K Sell
18,563
-32
-0.2% -$353 ﹤0.01% 4777
2022
Q4
$214K Buy
18,595
+1,392
+8% +$12.5K ﹤0.01% 4832
2022
Q3
$146K Buy
17,203
+2,578
+18% +$21.4K ﹤0.01% 5061
2022
Q2
$103K Sell
14,625
-6,798
-32% -$56.4K ﹤0.01% 5231
2022
Q1
$249K Sell
21,423
-969
-4% -$11.7K ﹤0.01% 5053
2021
Q4
$287K Buy
22,392
+886
+4% +$11.2K ﹤0.01% 5021
2021
Q3
$294K Sell
21,506
-384
-2% -$5.36K ﹤0.01% 4889
2021
Q2
$352K Sell
21,890
-290,392
-93% -$3.98M ﹤0.01% 4777
2021
Q1
$4.65M Buy
312,282
+5,636
+2% +$84.9K ﹤0.01% 3971
2020
Q4
$4.61M Buy
306,646
+12,928
+4% +$210K ﹤0.01% 3750
2020
Q3
$4.86M Buy
293,718
+28,405
+11% +$399K ﹤0.01% 3583
2020
Q2
$3.44M Buy
265,313
+252,045
+1,900% +$3.31M ﹤0.01% 3662
2020
Q1
$104K Buy
13,268
+7,379
+125% +$99.7K ﹤0.01% 4345
2019
Q4
$77K Buy
+5,889
New +$72K ﹤0.01% 4479

Other funds holding TELA

BlackRock's TELA Position: Q2 2026 in Review

BlackRock reduced its TELA Bio (TELA) stake by 20% in Q2 2026, selling an estimated $74.7K and leaving 374,516 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #4721.

BlackRock first reported a position in TELA in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.2M in Q2 2023. 15 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • BlackRock held 374,516 shares of TELA Bio worth $281K as of Q2 2026.
  • BlackRock sold 91,298 TELA Bio shares in Q2 2026, an estimated $74.7K.
  • TELA Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4721 holding.
  • BlackRock first reported a position in TELA Bio in Q4 2019 and has held it in 27 quarters since.
  • BlackRock's TELA Bio position peaked at $10.2M in Q2 2023.
  • 15 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.